Restoring Perivascular Adipose Tissue Function in Obesity Using Exercise

Purpose Perivascular adipose tissue (PVAT) exerts an anti-contractile effect which is vital in regulating vascular tone. This effect is mediated via sympathetic nervous stimulation of PVAT by a mechanism which involves noradrenaline uptake through organic cation transporter 3 (OCT3) and beta(3)-adrenoceptor-mediated adiponectin release. In obesity, autonomic dysfunction occurs, which may result in a loss of PVAT function and subsequent vascular disease. Accordingly, we have investigated abnormalities in obese PVAT, and the potential for exercise in restoring function. Methods Vascular contractility to electrical field stimulation (EFS) was assessed ex vivo in the presence of pharmacological tools in +/- PVAT vessels from obese and exercised obese mice. Immunohistochemistry was used to detect changes in expression of beta(3)-adrenoceptors, OCT3 and tumour necrosis factor-alpha (TNF alpha) in PVAT. Results High fat feeding induced hypertension, hyperglycaemia, and hyperinsulinaemia, which was reversed using exercise, independent of weight loss. Obesity induced a loss of the PVAT anti-contractile effect, which could not be restored via beta(3)-adrenoceptor activation. Moreover, adiponectin no longer exerts vasodilation. Additionally, exercise reversed PVAT dysfunction in obesity by reducing inflammation of PVAT and increasing beta(3)-adrenoceptor and OCT3 expression, which were downregulated in obesity. Furthermore, the vasodilator effects of adiponectin were restored. Conclusion Loss of neutrally mediated PVAT anti-contractile function in obesity will contribute to the development of hypertension and type II diabetes. Exercise training will restore function and treat the vascular complications of obesity.

Automated summary

PVAT plays a crucial role in regulating vascular tone through its anti-contractile effect, which can be compromised in obesity. Exercise has been shown to reverse PVAT dysfunction in obesity by reducing inflammation, increasing expression of beta(3)-adrenoceptors and OCT3, and restoring the vasodilator effects of adiponectin.